Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Ipilimumab & Nivolumab Combo. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on September 22, 2018.
